Myc protein expression correlates withMYCamplification in small-cell lung carcinoma
- 20 January 2015
- journal article
- Published by Wiley in Histopathology
- Vol. 67 (1), 81-89
- https://doi.org/10.1111/his.12622
Abstract
Myc family members are important contributors to oncogenesis in a variety of tumours. Identification of therapeutic targets is needed in small-cell lung carcinoma (SCLC), an aggressive disease with limited treatment options. Sequencing studies have identified MYC amplification in 2-7% of SCLCs. This study aims to determine the rate of MYC gene amplification and its correlation with Myc protein overexpression in SCLC.One hundred and three cases of formalin-fixed, paraffin-embedded SCLC were examined. Myc protein expression was scored according to the extent of immunohistochemical staining. MYC copy number (CN) was evaluated with dual-colour chromogenic in-situ hybridization (CISH) for the MYC locus and a chromosome 8 (Chr8) centromeric control. Amplification was defined as a MYC/Chr8 ratio of ≥2. Thirty-eight per cent of SCLCs had some degree of Myc protein expression, and 9% of cases were MYC-amplified. MYC CN was significantly correlated with the extent of Myc protein expression (Spearman's ρ = 0.57, P < 0.01). There was no significant association between Myc expression or CN and clinicopathological features.MYC amplification by CISH was identified in 9% of SCLCs, and correlated with protein expression. As novel Myc-targeted therapies are developed, CISH and IHC should be considered as biomarkers of Myc pathway dysregulation in SCLC.Keywords
This publication has 42 references indexed in Scilit:
- Genome‐wide identification of genes with amplification and/or fusion in small cell lung cancerGenes, Chromosomes and Cancer, 2013
- A framework for identification of actionable cancer genome dependencies in small cell lung cancerProceedings of the National Academy of Sciences of the United States of America, 2012
- Transcriptional Amplification in Tumor Cells with Elevated c-MycCell, 2012
- Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell LymphomasPLOS ONE, 2012
- Targeting MYC dependence in cancer by inhibiting BET bromodomainsProceedings of the National Academy of Sciences of the United States of America, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancerProceedings of the National Academy of Sciences of the United States of America, 2010
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- Hematopoietic Stem Cell Function and Survival Depend on c-Myc and N-Myc ActivityCell Stem Cell, 2008
- Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization studyLaboratory Investigation, 2005